Evaluating the Scientific Evidence
for Potential Reduced-Risk Tobacco Products
 

Core Committee Meeting
February 23-24, 2005
Bethesda, MD

Agenda


      Wednesday, February 23, 2005
Information Gathering Session
      I.    Welcome and Participant Introductions
Dr. Michael Falk, Executive Director
      II.    Background Information on LSRO
Dr. Michael Falk
      III.    Introduction to Project
Dr. Catherine St. Hilaire, Project Leader
      IV.    Tobacco Harm Reduction
a.Overview of Clearing the Smoke
Dr. Kathleen Stratton
Institute of Medicine
b.Overview of NIH Research Initiatives
Dr. Mark Parascandola
Tobacco Control Research Branch
National Cancer Institute
      V.    Discussion Period
 
      Lunch
      VI.    Luncheon speaker:  Dr. Daniel Byrd III
   Summary of LSRO Added Ingredients Review, Phases I & II
 
      Executive Session
      VII.    Committee Discussion of LSRO Guidelines for Risk-Related Projects
      VIII.    Charge to the Committee
Dr. Catherine St. Hilaire
      IX.    Literature Review and Evaluation
Dr. Amy Brownawell
      X.    Discussion of Terminology, Definitions and Principles
Dr. Catherine St. Hilaire
 
     
Thursday, February 24, 2005

Executive Session
      I.    Evaluative [Risk Assessment] Process
Dr. Catherine St. Hilaire
      II.    Biological Effects Assessment
Dr. Amy Brownawell
      III.    Exposure Assessment
Dr. Kara Lewis
      IV.    Exposure Assessment (Population)
Dr. Keith Lenghaus
      V.    Characterization of Exposure/Risk/Harm Reduction
Dr. Catherine St. Hilaire
      VI.    Case Study
Project Staff
      VII.    Next Steps
a. March Meeting
b. Assignments
c. Discussion of SOSR Committees
d. Other